Who are in the management team of Aquestive Therapeutics, Inc.?

Jun 22 2025 10:34 PM IST
share
Share Via
As of March 2022, the management team of Aquestive Therapeutics, Inc. includes Mr. Santo Costa (Independent Chairman), Mr. Keith Kendall (CEO), Mr. John Cochran (Vice Chairman), and several independent directors: Mr. Douglas Bratton, Dr. Gregory Brown, Ms. Nancy Lurker, and Mr. James Scibetta. They oversee the company's strategic direction and operations.
As of March 2022, the management team of Aquestive Therapeutics, Inc. includes the following individuals:
- Mr. Santo Costa, Independent Chairman of the Board - Mr. Keith Kendall, President, Chief Executive Officer, and Director - Mr. John Cochran, Vice Chairman of the Board - Mr. Douglas Bratton, Independent Director - Dr. Gregory Brown, Independent Director - Ms. Nancy Lurker, Independent Director - Mr. James Scibetta, Independent Director This team is responsible for guiding the strategic direction and operations of the company.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News